Back
44
Also listed as
FPAFF
OTC
Day Range
$3.58
$3.63
52-Week Range
$2.67
$4.44
Volume
13,564
50D / 200D Avg
$3.99
/
$4.02
Prev Close
$3.63
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 5.1 | 10.4 |
| P/B | 0.8 | 1.2 |
| ROE % | 15.8 | 12.6 |
| Net Margin % | 6.0 | 5.3 |
| Rev Growth 5Y % | 9.0 | 5.5 |
| D/E | 3.2 | 0.6 |
Key Takeaways
Revenue grew 8.98% annually over 5 years — modest growth
Earnings grew 19.77% over the past year
ROE of 15.77% — decent returns on equity
Debt/Equity of 3.21 — high leverage
Generating 388.10M in free cash flow
P/E of 5.13 — trading at a low valuation
Growth
Revenue Growth (5Y)
8.98%
Revenue (1Y)-4.31%
Earnings (1Y)19.77%
FCF Growth (3Y)-41.21%
Quality
Return on Equity
15.77%
ROIC9.97%
Net Margin5.97%
Op. Margin21.87%
Safety
Debt / Equity
3.21
Current Ratio1.35
Interest Coverage3.62
Valuation
P/E Ratio
5.13
P/B Ratio0.78
EV/EBITDA5.84
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4.31% | Revenue Growth (3Y) | -1.21% |
| Earnings Growth (1Y) | 19.77% | Earnings Growth (3Y) | 23.81% |
| Revenue Growth (5Y) | 8.98% | Earnings Growth (5Y) | 45.89% |
| Profitability | |||
| Revenue (TTM) | 10.06B | Net Income (TTM) | 600.30M |
| ROE | 15.77% | ROA | 2.09% |
| Gross Margin | 36.34% | Operating Margin | 21.87% |
| Net Margin | 5.97% | Free Cash Flow (TTM) | 388.10M |
| ROIC | 9.97% | FCF Growth (3Y) | -41.21% |
| Safety | |||
| Debt / Equity | 3.21 | Current Ratio | 1.35 |
| Interest Coverage | 3.62 | Dividend Yield | 0.06% |
| Valuation | |||
| P/E Ratio | 5.13 | P/B Ratio | 0.78 |
| P/S Ratio | 0.31 | PEG Ratio | 0.24 |
| EV/EBITDA | 5.84 | Dividend Yield | 0.06% |
| Market Cap | 3.08B | Enterprise Value | 12.84B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 10.06B | 10.51B | 10.30B | 9.10B | 7.13B |
| Net Income | 600.30M | 501.20M | 391.60M | 244.50M | 132.50M |
| EPS (Diluted) | 0.70 | 0.60 | 0.46 | 0.28 | 0.15 |
| Gross Profit | 3.65B | 3.37B | 3.06B | 2.83B | 2.31B |
| Operating Income | 2.20B | 2.06B | 1.77B | 1.37B | 1.07B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 28.68B | 27.36B | 25.49B | 26.57B | 26.94B |
| Total Liabilities | 16.75B | 15.79B | 15.13B | 15.95B | 16.32B |
| Shareholders' Equity | 3.93B | 3.69B | 3.30B | 3.30B | 3.14B |
| Total Debt | 12.62B | 11.71B | 11.22B | 11.13B | 10.71B |
| Cash & Equivalents | 2.86B | 2.35B | 2.09B | 2.25B | 1.35B |
| Current Assets | 6.74B | 6.06B | 5.18B | 5.81B | 5.98B |
| Current Liabilities | 4.99B | 4.59B | 4.11B | 4.62B | 4.83B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#202 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026